Sheba Medical Center
PET-CT with Gallium 68 (DOTATATE) in Israel costs from $2,400 to $3,500. The price depends on the specific diagnostic protocol used and the clinic tier. Patients save around 40% compared to the US, where this diagnostic costs $4,800 on average. Advanced assessments for neuroendocrine tumors are available in cities like Tel Aviv, Jerusalem, and Ramat Gan.
Bookimed Expert Insight: Choosing a bundled diagnostic program for neuroendocrine tumors often provides better value. A program at Sheba Medical Center costs approximately $5,000 for a detailed assessment. This price includes consultations with experts like Dr. Amit Tirosh and necessary imaging scans. Sheba Medical Center was ranked among the global Top 10 hospitals by Newsweek in 2026. This approach ensures a multidisciplinary team reviews your Gallium-68 DOTATATE results immediately. Sourasky Medical Center also offers high success rates with nuclear medicine specialists like Dr. Einat Even-sapir.
| Israel | Turkey | Austria | |
| PET-CT with Gallium 68 (DOTATATE) | from $2,350 | from $750 | from $2,150 |
No hidden fees – just official clinic prices. Pay at the clinic for PET-CT with Gallium 68 (DOTATATE) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in PET-CT with Gallium 68 (DOTATATE) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your PET-CT with Gallium 68 (DOTATATE) journey.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Professor Ido Nachmany is a Forbes-ranked top physician in Israel. He heads the General Surgery Department at the prestigious Sheba Medical Center.
Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He specializes in the surgical treatment of complex cancers identified by PET-CT with Gallium 68.
Prof. Amit Tirosh heads the Neuroendocrine Tumors Service at Sheba Medical Center. He uses PET-CT with Gallium 68 (DOTATATE) to locate and stage complex endocrine tumors.